NeoGenomics
134 hedge funds and large institutions have $572M invested in NeoGenomics in 2017 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 49 increasing their positions, 35 reducing their positions, and 22 closing their positions.
35,150% more call options, than puts
Call options by funds: $705K | Put options by funds: $2K
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
40% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 35
19% more capital invested
Capital invested by funds: $481M → $572M (+$90.8M)
3.19% more ownership
Funds ownership: 77.38% → 80.56% (+3.2%)
6% less funds holding
Funds holding: 143 → 134 (-9)
27% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$18.3M |
| 2 |
FPC
Falcon Point Capital
San Francisco,
California
|
+$6.74M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
+$6.3M |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$5.4M |
| 5 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$3.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$7.34M |
| 2 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
-$5.68M |
| 3 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$4.31M |
| 4 |
Renaissance Technologies
New York
|
-$2.44M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$2.36M |
NEO Hedge Fund Activity: Q2 2017 in Review
134 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q2 2017, worth a combined $572M — up 19% from $481M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of NEO and 16 opened new positions — a net loss of 6 holders — while 35 trimmed existing stakes and 49 added.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $18.3M. The largest seller was Driehaus Capital Management, cutting an estimated $7.34M.
- 134 institutional investors held NeoGenomics (NEO) as of Q2 2017, down from 143 in Q1 2017.
- Funds reported $572M of NeoGenomics stock for Q2 2017, up 19% quarter-over-quarter.
- 16 funds opened new NeoGenomics positions in Q2 2017 and 22 closed out, a net change of -6 holders.
- The largest NeoGenomics buyer in Q2 2017 was Janus Henderson Group, an estimated $18.3M added.
- The largest NeoGenomics seller in Q2 2017 was Driehaus Capital Management, an estimated $7.34M sold.
Based on aggregated 13F filings for Q2 2017.